reglab/housing_qa huggingface dataset:
NH Rev Stat § 318:51-g (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:51-g - Licensure of Drug or Device Distribution Agents.

    318:51-g Licensure of Drug or Device Distribution Agents. –||I. No person shall act as a prescription drug or device distribution agent, which includes controlled drugs as the term is defined in RSA 318-B:1, VI, without first having obtained a license to do so from the board.||II. Any person licensed pursuant to this section shall be subject to the provisions of RSA 318:29.||III. For purposes of this section:||(a) A drug or device distribution agent shall include virtual manufacturers, virtual wholesaler distributors, jobbers or brokers (including sales/marketing offices), and third-party logistics companies, and any other agent involved in the handling or distribution of prescription drugs, medical gases, or prescription medical devices or equipment in the supply chain that affects the pedigree of the products.||(b) "Broker or jobber" is any party that mediates between a buyer and a seller for the sale or shipment of prescription drugs, gases, equipment, or devices.||(c) "Pedigree" is a document or an electronic file containing information that records each distribution of any given prescription drug, medical gas, or prescription medical device or equipment.||(d) "Third-party logistics provider" is a person that contracts with a wholesale distributor or a manufacturer to provide or coordinate warehousing, wholesale distribution, or other services on behalf of a manufacturer, but does not take title to the prescription drug, gas, device, or equipment.||(e) "Virtual manufacturer" is anyone that owns the NDA or ANDA for a prescription drug, gas, device, or equipment that contracts with others for the actual manufacturing.||(f) "Virtual wholesale distributor" is anyone engaged in wholesale distribution of prescription drugs, gases, devices, or equipment.|||Source. 2019, 264:14, eff. Sept. 17, 2019.|
NH Rev Stat § 318:52 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52 - Repealed by 1971, 135:2, eff. July 20, 1971.

    318:52 Repealed by 1971, 135:2, eff. July 20, 1971. –|
NH Rev Stat § 318:52-a (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52-a - Fraud or Deceit.

    318:52-a Fraud or Deceit. –||It is unlawful to obtain or attempt to obtain a drug or device sold by prescription of a physician, dentist, optometrist, podiatrist, veterinarian, naturopathic doctor, physician assistant, or advanced practice registered nurse that bears a statement that it is to be dispensed or sold only by or on the prescription of a physician, dentist, optometrist, podiatrist, veterinarian, naturopathic doctor, physician assistant, or advanced practice registered nurse by:||I. Fraud, deceit, misrepresentation or subterfuge;||II. The forgery or alteration of a prescription or of any written order;||III. The concealment of a material fact;||IV. The use of a false name or the giving of a false address; or||V. Submission of an electronic or on-line medical history form that fails to establish a valid practitioner-patient relationship.|||Source. 1965, 275:1. 1994, 333:13. 2009, 54:5. 2010, 74:2, eff. Jan. 1, 2011; 259:10, eff. July 6, 2010; 259:12, eff. Jan. 1, 2011 at 12:01 a.m.|
NH Rev Stat § 318:52-b (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52-b - Destruction of Used Instruments in Health Care Facilities.

    318:52-b Destruction of Used Instruments in Health Care Facilities. –||It shall be unlawful for any possessor of a hypodermic syringe, needle, or any instrument adapted for the administration of controlled drugs, in health care facilities, to dispose of or discard any such instrument in any manner other than that provided in this section. Disposables which can cause injury, such as needles or syringes with needles, shall be placed intact in puncture resistant containers that are adapted with a secured lid which prevents easy access to the contents.|||Source. 1970, 48:2. 1989, 34:1. 1990, 129:1, eff. June 18, 1990.|
NH Rev Stat § 318:52-c (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52-c - Sale of Hypodermic Syringes and Needles.

    318:52-c Sale of Hypodermic Syringes and Needles. –||I. No person shall sell, furnish, or give to any person, under 18 years of age, an instrument commonly known as a hypodermic syringe, hypodermic needle, or any instrument adapted for the administration of drugs by injection without the written or oral prescription of a licensed physician, physician assistant, dentist, veterinarian, podiatrist, or advanced practice registered nurse. Such prescription shall contain the name and address of the patient, the date of the prescription, the description of the instrument prescribed, and the number of instruments prescribed.||II. The following conditions shall apply to all purchases of hypodermic syringes or needles:||(a) Retailers and dispensers of hypodermic syringes, needles, or any instrument adapted for the administration of drugs by injection shall provide to each purchaser at the time of purchase information regarding the safe disposal of hypodermic syringes or needles, including local disposal locations or a telephone number to call for such information, if appropriate.||(b) Retailers and dispensers shall also provide purchasers with information on drug addiction treatment, including a local telephone number to get assistance, if appropriate.|||Source. 1971, 135:1. 1973, 453:12. 1981, 484:15. 1989, 34:2. 1992, 102:1. 1994, 333:14. 1999, 213:5. 2000, 176:1. 2005, 177:135. 2009, 54:5. 2012, 171:26, XII, eff. Aug. 10, 2012. 2017, 117:2, eff. June 16, 2017.|
NH Rev Stat § 318:52-d (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52-d - Repealed by 2017, 117:6, eff. June 16, 2016.

    318:52-d Repealed by 2017, 117:6, eff. June 16, 2016. –|
NH Rev Stat § 318:52-e (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:52-e - Control or Possession of Hypodermic or Like Instruments Without Prescription Prohibited for Minors.

    318:52-e Control or Possession of Hypodermic or Like Instruments Without Prescription Prohibited for Minors. –||No person under 18 years of age shall have under such person's control or possess a hypodermic syringe, hypodermic needle, or any instrument adapted for the administration of drugs by injection, unless the person has received a written or oral prescription issued under RSA 318:52-c. For the purpose of this subdivision, no such prescription shall be valid which has been outstanding for more than one year.|||Source. 1971, 135:1. 1973, 453:15. 1981, 484:16. 1989, 34:4. 1994, 333:15. 1999, 213:6. 2000, 176:3, eff. Jan. 1, 2001.|
NH Rev Stat § 318:53, 318:54 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:53, 318:54 - Repealed by 1963, 276:2, eff. July 1, 1963

    318:53, 318:54 Repealed by 1963, 276:2, eff. July 1, 1963 –|
NH Rev Stat § 318:55 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:55 - Fines and Imprisonment; Penalties.

    318:55 Fines and Imprisonment;  Penalties. –||I. Any person violating the provisions of this chapter, except as otherwise provided, shall be guilty of a misdemeanor if a natural person, or guilty of a felony if any other person.||II. In addition to the penalties under paragraph I, the board may impose a civil penalty not to exceed $5,000 per violation upon any person who willfully or repeatedly violates any provision of this chapter.||III. For any order issued in resolution of a disciplinary proceeding before the board, the board may require that any licensee, permittee, registrant, or certificate holder found guilty of a charge involving any drug law or rule to pay to the board a sum not to exceed the reasonable cost of investigation and prosecution of the proceeding. The sum shall not exceed $5,000. The costs to be assessed shall be fixed by the board and any sums recovered shall be paid to the state treasurer for deposit in the office of professional licensure and certification fund.|||Source. 1909, 162:4. 1921, 122:30. PL 210:54. 1933, 61:2. RL 256:55. RSA 318:55. 1973, 528:203; 529:70. 1989, 258:4. 2007, 202:13, eff. Jan. 1, 2008. 2021, 197:104, eff. July 1, 2021.|
NH Rev Stat § 318:56 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:56 - Unused Prescription Drug Program Established.

    318:56 Unused Prescription Drug Program Established. –||There is established the unused prescription drug program for the purpose of allowing the donation of unused prescription drugs and medical devices to uninsured or underinsured individuals. The program shall be administered by the New Hampshire pharmacy board.|||Source. 2006, 152:1, eff. July 21, 2006.|
NH Rev Stat § 318:57 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:57 - Definitions.

    318:57 Definitions. –||In this subdivision:||I. "Board" means the New Hampshire pharmacy board.||II. "Medical device" means an instrument, apparatus, implement, machine, or similar article, or any attachment or component part thereof, that has been prescribed by a physician or other authorized health care practitioner.||III. "Patient" means a person to whom a drug or a medical device has been prescribed, that patient's authorized representative, or the executor or administrator of the patient's estate.||IV. "Prescription drug" means a drug as defined in RSA 318:1, XVII, excluding any controlled drug as defined in RSA 318-B:1, VI.||V. "Program" means the unused prescription drug program.|||Source. 2006, 152:1, eff. July 21, 2006.|
NH Rev Stat § 318:58 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:58 - Donating, Accepting, and Redispensing Unused Drugs.

    318:58 Donating, Accepting, and Redispensing Unused Drugs. –||I. Any patient, or other person or entity authorized to possess prescription drugs and medical devices pursuant to RSA 318, including manufacturers and wholesalers licensed under RSA 318:51-a or other law, including any nursing home or long-term care facility licensed under RSA 151 or any correctional facility, may donate unused prescription drugs and medical devices to the program.||II. Any person authorized to dispense prescription drugs and medical devices pursuant to RSA 318 or other law may redispense such drugs and devices for the purposes of the program.||III. The following facilities and services may accept donations of unused prescription drugs and medical devices for the program:||(a) Any pharmacy as defined in RSA 318:1, XI;||(b) Any hospital, nursing home, hospice, or outpatient clinic licensed pursuant to RSA 151;||(c) New Hampshire hospital, Glencliff home, New Hampshire veterans home, and the state and county correctional facilities; and||(d) Any licensed prescriber of prescription drugs pursuant to RSA 318:42, II.||III-a. Any facility authorized to accept prescription drugs and devices for the program may temporarily store the drugs and devices appropriately but separately from the usual storage of such drugs and devices for the sole purpose of redispensing to individuals as provided in this section.||IV. The following prescription drugs and medical devices may be accepted and redispensed through the program; provided, that they have not been in the possession of the patient or other member of the public:||(a) Unused prescription drugs, including manufacturer's samples, that have not reached their expiration date, are contained in unopened unit dose or other tamper-evident packaging, and show no evidence of contamination; and||(b) Medical devices that have not been opened or adulterated.||V. Unused prescription drugs and medical devices may not be resold, but the facility or service redispensing such drug or device may charge a handling fee for the service not to exceed $15.||VI. A facility or service may redispense unused prescription drugs and medical devices under the program to uninsured or underinsured persons as defined by the board, but redispensing to other patients is permitted if no uninsured or underinsured person is available.||VII. Participation in the program shall be voluntary and individuals in the program shall be informed that the prescription drugs and medical devices have been redispensed.|||Source. 2006, 152:1. 2007, 263:12. 2010, 89:1, 2. 2011, 41:1, eff. July 8, 2011; 99:1, eff. July 26, 2011.|
NH Rev Stat § 318:58-a (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:58-a - Repealed by 2018, 147:2, eff. Nov. 30, 2018.

    318:58-a Repealed by 2018, 147:2, eff. Nov. 30, 2018. –|
NH Rev Stat § 318:59 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:59 - Rulemaking.

    318:59 Rulemaking. –||The board shall, not later than December 31, 2010, adopt rules, pursuant to RSA 541-A, for the program relative to:||I. Standards and procedures for the donation, acceptance, storage, and redispensing of unused prescription drugs and medical devices.||II. Eligibility of individuals to receive unused drugs.||III. The maximum allowable handling fee for redispensing drugs and devices.||IV. Content and format of all forms required under this subdivision.||V. Further definition of persons and entities which may donate unused prescription drugs and medical devices.|||Source. 2006, 152:1. 2010, 89:3. 2011, 41:2, eff. July 8, 2011.|
NH Rev Stat § 318:60 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:60 - Limited Immunity.

    318:60 Limited Immunity. –||I. Accepting or dispensing of a prescription drug manufactured by the prescription drug manufacturer that is donated by any entity pursuant to this subdivision shall not subject a prescription drug manufacturer to criminal or civil liability for injury, death, or loss to person or property for failure to transfer or communicate product or consumer information or the expiration date of the donated prescription drug, or for damages related to improper storage of the donated prescription drug or use after the expiration date. Except as provided in this section, nothing in this subdivision shall in any way limit liability that would have existed under the original prescription.||II. Pharmacies, pharmacists, and other persons or entities acting in good faith, participating in the unused prescription drug program, and students and faculty of medical and pharmacy education institutions, with respect to the duties they perform as part of the program, shall not be subject to criminal or civil liability for injury, death, or loss to person or property for damages related to improper storage of the donated prescription drug or use after the expiration date, provided they comply with rules adopted by the board.|||Source. 2006, 152:1. 2010, 89:4, eff. July 24, 2010.|
NH Rev Stat § 318:61 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:61 - Definition.

    318:61 Definition. –||In this subdivision, "responsible party" means the entity responsible for payment of claims for health care services other than the individual to whom the health care services were rendered or that individual's guardian or legal representative.|||Source. 2013, 159:1, eff. Jan. 1, 2014.|
NH Rev Stat § 318:63 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:63 - Mandatory Appeals Process.

    318:63 Mandatory Appeals Process. –||I. Each entity that conducts an audit of a pharmacy shall establish an appeals process under which a pharmacy may appeal within 30 days after the report an unfavorable audit report to the entity.||II. If, following the appeal, the entity finds that an unfavorable audit report or any portion of the unfavorable audit report is unsubstantiated, the entity shall dismiss the unsubstantiated portion of the audit report without any further proceedings unless outlined in the contract.||III. Each entity conducting an audit shall provide a copy, if required under contractual terms, of the audit findings to the plan sponsor after completion of any appeals process.||IV. If any portion of an unfavorable audit report is not dismissed within 30 days after an appeal is made under paragraph I, the pharmacy may request a hearing from the insurance department pursuant to RSA 400-A:17.|||Source. 2013, 159:1, eff. Jan. 1, 2014. 2020, 39:11, eff. Sept. 27, 2020.|
NH Rev Stat § 318:64 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:64 - Pharmacy Audit Recoupments.

    318:64 Pharmacy Audit Recoupments. –||I. Recoupments of any disputed funds shall occur only after final internal disposition of an audit, including the appeals process, unless fraud or misrepresentation is reasonably suspected or the discrepant amount exceeds $10,000.||II. Recoupment on an audit shall be refunded to the responsible party as contractually agreed upon by the parties.||III. The entity conducting the audit shall not charge or assess the responsible party, directly or indirectly, based on amounts recouped.|||Source. 2013, 159:1, eff. Jan. 1, 2014. 2020, 39:12, eff. Sept. 27, 2020.|
NH Rev Stat § 318:65 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:65 - Audit Information and Reports.

    318:65 Audit Information and Reports. –||An audit report shall be delivered to the pharmacy within 75 days, unless otherwise agreed to, after the conclusion of the audit. A pharmacy shall be allowed at least 30 days, unless otherwise agreed to, following receipt of the audit report to appeal any discrepancy found in the audit. A final audit report shall be delivered to the pharmacy within 90 days, unless otherwise agreed to, after receipt of the appeal. A charge-back, recoupment, or other penalty may not be assessed until the appeal process has been exhausted and the final report issued except as specified in RSA 318:64. Except as provided by state or federal law or contract, audit information may not be shared. Auditors may have access only to previous audit reports on a particular pharmacy conducted by that same entity.|||Source. 2013, 159:1, eff. Jan. 1, 2014.|
NH Rev Stat § 318:66 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:66 - Applicability.

    318:66 Applicability. –||This subdivision shall not apply to any audit, review, or investigation that is based on suspected or alleged fraud, willful misrepresentation, or abuse. Nothing in this subdivision shall apply to claims that were paid for in part or in whole by Medicare or Medicaid program funds.|||Source. 2013, 159:1, eff. Jan. 1, 2014.|
NH Rev Stat § 318:67 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:67 - Definitions.

    318:67 Definitions. –||In this subdivision:||I. "Department" means the insurance department.||II. "Manufacturer" means any entity which is engaged in the production, preparation, propagation, compounding, conversion, or processing of prescription drugs, whether directly or indirectly by extraction from substances of natural origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, or any entity engaged in the packaging, repackaging, labeling, relabeling, or distribution of prescription drugs. The term shall not include a wholesale distributor of prescription drugs, a retailer, or a pharmacist licensed under the board.||III. "Prescription drug" means a drug defined in 21 U.S.C. section 321.|||Source. 2020, 4:1, eff. Jan. 1, 2020.|
NH Rev Stat § 318:68 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318 - Pharmacists and Pharmacies|Section 318:68 - Notice Required.

    318:68 Notice Required. –||I. A prescription drug manufacturer shall notify the department in writing if it is introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program. The manufacturer shall provide the written notice within 3 calendar days following the release of the drug in the commercial market. A manufacturer may make the notification pending approval by the United States Food and Drug Administration (FDA) if commercial availability is expected within 3 calendar days following the approval.||II. No later than 30 calendar days following notification required under paragraph I, the manufacturer shall provide the following information to the department in a format that the department prescribes:||(a) A description of the marketing and pricing plans used in the launch of the new drug in the United States and internationally.||(b) The estimated volume of patients who may be prescribed the drug.||(c) Whether the drug was granted breakthrough therapy designation or priority review by the FDA prior to final approval.||(d) The date and price of acquisition if the drug was not developed by the manufacturer.||III. The manufacturer may limit the information required under paragraph II to that which is otherwise in the public domain or publicly available.||IV. The department shall publish on its Internet website, at least quarterly, the information reported to it under this section. The information shall be published in a manner that identifies the information that is disclosed on a per-drug basis and shall not be aggregated in a manner that would not allow identification of the drug.||V. The attorney general may bring a civil action for injunctive relief, costs, and attorney's fees and impose on a manufacturer that fails to provide the information required under paragraph II, a civil penalty of not more than $1,000 per day for every day after the notification period described in paragraph II that the required information is not reported. In any action brought under this section, the attorney general shall have the same authority to investigate and obtain remedies as if the action were brought under the RSA 358-A.|||Source. 2020, 4:1, eff. Jan. 1, 2020.|